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Diabetic renal 
diseases and invading 
macrophages 
Infl ammatory macrophages have 
emerged as critical mediators of 
a number of renal diseases. Two 
papers in this issue highlight 
their role in diabetic nephropathy 
and in obstructive renal disease. 
Macrophages leave the circulation in 
response to a number of cytokines, 
including monocyte chemoattractant 
protein-1 (MCP-1). Experimental 
and human diabetic nephropathy is 
associated with increased expression 
of MCP-1, at least in the urine. In 
this issue, Tesch et al. show that mice 
whose MCP-1 genes were deleted 
accumulated fewer macrophages in 
their kidneys on induction of diabetic 
nephropathy. Further, invading 
macrophages did not seem to be 
activated, which might explain why 
the mice did not develop proteinuria 
or renal failure on progression of 
diabetes. Histological studies showed 
that whereas wild-type mice developed 
glomerular hypertrophy, tubular 
atrophy, and fi brosis, mice lacking 
MCP-1 were largely protected. Th ese 
results demonstrate a dependence of 
global renal damage on the ability of 
macrophages to respond to MCP-1 and 
to presumably secreted infl ammatory 
mediators. Th is information off ers 
a rational basis for developing new 
reagents that interrupt diabetic renal 
fi brosis. See page 73. 
Obstructive renal 
diseases and invading 
macrophages 
In a related study, Lange-Sperandio et 
al. examined the role of macrophages 
in obstructive nephropathy, in which 
acute obstruction of the ureters 
results in rapid development of renal 
fi brosis. Entry of macrophages into 
the interstitium requires upregulation 
of their adhesion molecules, such 
as lymphocyte function-associated 
antigen-1 (LFA-1) and myeloid cell-
associated marker CD11b (Mac-1), as 
well as endothelial counter-receptors 
such as intercellular adhesion 
molecule-1 (ICAM-1). LFA-1 and 
Mac-1 are members of the β2 integrin 
family of receptors, as are other 
recently identifi ed surface molecules 
such as receptor for advanced glycation 
end products (RAGE) and junctional 
adhesion molecule. When the authors 
obstructed one ureter in newborn 
mice, macrophage invasion was 
marked in wild-type control mice and 
severely attenuated in Mac-1 deleted 
mice, but it was the same in LFA-1-
deleted mice compared with controls. 
Remarkably, ureteric obstruction 
resulted in the upregulation of RAGE 
and junctional adhesion molecule-
1 receptors. Th ere was also severe 
attenuation of tubular damage in the 
Mac-1 knockout mice, which suggests 
that this β2 integrin receptor is critical 
for macrophage invasion and tubular 
damage in ureteric obstruction. 
Th is study off ers another avenue 
for developing a specifi c therapy 
for treating renal fi brosis following 
ureteric obstruction. See page 81.
LDL oxidation in 
chronic renal disease
Oxidative stress in end-stage renal 
disease is implicated in causing 
accelerated atherosclerosis. As 
they report in this issue, Balla et al. 
measured lipid peroxidation of LDL 
catalyzed by addition of heme in vitro. 
Th ey found that plasma ultrafi ltrates 
from normal subjects contained a 
low-molecular weight fraction that 
retarded the process; similarly, heme 
degradation was also retarded. When 
oxidized LDL was added to endothelial 
cells, it induced the expected increase 
in hemoxygenase-1 and ferritin. In 
addition, plasma ultrafi ltrates reduced 
the response to oxidative damage. 
Th is protective activity of plasma 
ultrafi ltrate was also present in uremic 
plasma and in plasma of patients 
before they were dialyzed. Aft er 
hemodialysis, however, the protective 
activity was reduced. Dialysis results 
in loss of many small molecules by 
diff usion or ultrafi ltration, some 
of which are antioxidants. When 
the authors tested many candidate 
molecules, some of them conferred 
the antioxidant activity to dialyzed 
plasma. Interestingly, some of these 
compounds existed in uremic plasma 
in signifi cantly high concentrations. 
Th is fi nding suggests that their 
removal might play a role in the 
accelerated atherosclerosis seen in 
end-stage renal disease. See page 144.
Prevention of 
hemodialysis 
catheter-related 
bacteremia
Hemodialysis is oft en initiated 
with the use of uncuff ed catheters. 
Catheter-related bacteremia is seen 
more oft en in uncuff ed than in cuff ed 
catheters. Indeed, many organizations 
and regulatory agencies recommend 
avoiding the use of uncuff ed catheters. 
In a prospective, randomized, clinical 
trial, Kim et al. tested the use of 
antibiotic-fi lled heparin locks applied 
to uncuff ed catheters in patients with 
renal failure during the interdialytic 
period. Th e antibiotics included a 
mixture of gentamicin and cefazolin. 
Control subjects were provided with 
heparin-fi lled locks without antibiotics. 
Th e antibiotic-fi lled heparin locks 
resulted in an almost tenfold reduction 
in the incidence of bacteremia. Th ese 
very encouraging results suggest that 
antibiotics should be used when dialysis 
is initiated with uncuff ed catheters. See 
page 161.
